LIANHE TECHNOLOGY(002250)2025-04-24 13:05Dividend Distribution - The company plans to distribute a cash dividend of 0.2 RMB per 10 shares to all shareholders, based on the total share capital excluding repurchased shares[4]. - The board of directors has approved the profit distribution plan, which will be executed on the share registration date[4]. - The company reported a cash dividend total of ¥97,812,841.16, which represents 100% of the total profit distribution amount[197]. - The distributable profit available for shareholders was ¥2,312,322,240.24, with a net profit of ¥156,917,873.10 for the fiscal year 2024[197]. - The company aims to maintain a minimum cash dividend ratio of 80% during profit distribution, reflecting its mature development stage[197]. - The cash dividend policy is compliant and transparent, with clear decision-making processes in place[196]. - The company has ensured that minority shareholders have opportunities to express their opinions and that their rights are protected[196]. Financial Performance - The company's operating revenue for 2024 was approximately ¥5.68 billion, a decrease of 11.88% compared to ¥6.44 billion in 2023[22]. - The net profit attributable to shareholders for 2024 was ¥103.14 million, a significant turnaround from a loss of ¥465.24 million in 2023, representing a 122.17% increase[22]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥121.38 million, up 134.31% from a loss of ¥353.82 million in 2023[22]. - The net cash flow from operating activities increased by 14.83% to ¥1.24 billion in 2024, compared to ¥1.08 billion in 2023[22]. - The company's total assets at the end of 2024 were approximately ¥13.80 billion, a slight decrease of 0.80% from ¥13.91 billion at the end of 2023[22]. - The company's weighted average return on equity improved to 1.51% in 2024, compared to -6.68% in 2023, marking an increase of 8.19 percentage points[22]. - The company's financial expenses increased by 249.17% to ¥73,601,547.13, primarily due to reduced foreign exchange gains[120]. - The research and development expenses decreased by 22.53% to ¥291,064,608.45[120]. - R&D investment decreased by 22.53% from 375,716,722.56 CNY in 2023 to 291,064,608.45 CNY in 2024, representing 5.13% of revenue[122]. - The number of R&D personnel decreased by 11.30% from 761 in 2023 to 675 in 2024, with a notable decline in those under 30 years old by 16.34%[122]. - The company's cash flow from financing activities decreased by 49.82%, from 3,928,464,301.60 CNY in 2023 to 1,971,308,652.69 CNY in 2024[125]. - The total amount of accounts receivable increased by 0.87%, from 1,113,422,910.64 CNY in 2023 to 1,225,529,334.94 CNY in 2024[124]. Market Trends and Projections - The global crop protection industry is projected to reach a market size of approximately $75 billion in 2024, with a compound annual growth rate of 2.6% over the next five years[30]. - The global pharmaceutical market is projected to reach $1,718.8 billion by 2025 and $2,114.8 billion by 2030, with a compound annual growth rate (CAGR) of 4.2%[38]. - The global innovative drug market is expected to grow to $1,222.7 billion in 2025 and $1,545.5 billion in 2030, indicating a significant market share increase[38]. - China's pharmaceutical market is forecasted to reach ¥2,064.5 billion by 2025 and ¥2,739.0 billion by 2030, with a CAGR of 5.8%[39]. - The global CDMO market is anticipated to grow to $124.3 billion by 2025 and $231.0 billion by 2030, with a CAGR of 13.2%[40]. - China's CDMO market is projected to reach ¥157.1 billion by 2025, accounting for 19.6% of the global market, and ¥355.9 billion by 2030, representing 23.9% of the global market[40]. - The personal care and cosmetics market in China is expected to grow from ¥182.5 billion in 2014 to ¥435.7 billion in 2024, with a CAGR of 9.09%[46]. Research and Development - The company has established multiple R&D platforms to meet diverse customer needs across different stages of product development, enhancing its competitive edge in the agricultural protection sector[51]. - The company is actively expanding its CDMO and CRO services in the pharmaceutical sector, focusing on collaboration with major global pharmaceutical companies[56]. - The company aims to develop a series of specialized solvents and functional additives for the new energy market, leveraging its technological advantages in fine chemicals[58]. - The company has a strong technical innovation and incubation capability, recognized by global leading companies in the plant protection and pharmaceutical sectors[70]. - The company has accumulated rich technical reserves and process development experience over years of exploration in the chemical field[71]. - The company is focusing on R&D cooperation projects in the plant protection sector, aiming to enhance core competitiveness through resource integration and product development[76]. - The company has successfully applied efficient ligand catalysis and palladium recovery technology in commercial production, reducing precious metal usage and production costs[76]. - The company has upgraded its production technology, achieving breakthroughs in continuous nitration, diazotization, and photochemical reactions, improving safety and yield[80]. - The company aims to develop green enzyme catalysis technology and has made significant progress in establishing a fermentation platform for biopesticides and biofertilizers, with potential for large-scale production by 2025[76]. Operational Strategy - The company is expanding its market presence in the petrochemical, coal chemical, and new energy sectors by enhancing technical applications and product upgrades, transitioning from a single equipment manufacturer to a multi-solution provider[82]. - The company has established a comprehensive international management system, integrating safety, quality, environmental protection, and supply chain management, which has created a high management barrier in the industry[83]. - The company is committed to continuous investment in technology innovation and global supply chain layout to maintain its leading position in the industry[52]. - The company is constructing a new facility in Malaysia to diversify its supply chain and mitigate potential risks, with plans to provide more diversified solutions based on product lifecycle[90]. - The company is focusing on technological innovation and lean management to reduce manufacturing costs and improve operational efficiency[90]. - The company will continue to focus on sustainable development and enhance its SHEQ&C management system across various sectors, including agriculture, pharmaceuticals, and fine chemicals[150]. - The company acknowledges risks from macroeconomic fluctuations and environmental regulations, implementing strategies to mitigate these risks and enhance competitiveness[159][160]. - The company faces significant raw material cost fluctuations due to ongoing global conflicts and environmental issues, impacting operational performance[162]. - To mitigate risks, the company will enhance supply chain management and diversify product types to reduce reliance on single raw materials[162]. Governance and Management - The company has established a governance structure that complies with relevant laws and regulations, ensuring strong independence and standardized operations[170]. - The board consists of seven directors, with three independent directors, meeting legal requirements and ensuring diverse expertise[171]. - The company maintains complete independence from its controlling shareholder in terms of business, personnel, assets, and finance, ensuring autonomous operations[174]. - The company has implemented a stock incentive plan for subsidiaries to align interests between shareholders and key personnel, promoting long-term stability[171]. - The company has a dedicated financial department with an independent accounting system, ensuring financial decision-making autonomy[174]. - The company has a robust information disclosure system, ensuring timely and accurate communication with investors and regulatory bodies[173]. - The company has established a transparent performance evaluation and incentive mechanism for management, enhancing accountability and alignment with corporate goals[171]. - The total number of shares held by the board and management reflects a strong commitment to the company, with significant personal investments noted[178]. - The company’s governance structure includes a mix of experienced professionals from various industries, enhancing its strategic decision-making capabilities[179][180]. Employee Engagement and Training - The total number of employees at the end of the reporting period is 5,403, with 958 in the parent company and 4,445 in major subsidiaries[190]. - The company conducted 5,222 internal offline training sessions in 2024, totaling 7,032 hours and reaching 85,279 participants[193]. - The company offers 188 online learning courses, with 1,238 participants in 2024[193]. - The company has 39 employees with doctoral degrees and 230 with master's degrees, reflecting a diverse educational background[190]. - The company emphasizes internal fairness in its compensation management, aligning salaries with job responsibilities and market conditions[191]. - The company has implemented a performance evaluation system to determine variable bonuses based on employee contributions[191]. Compliance and Risk Management - The company has established a comprehensive internal control system covering itself and 15 subsidiaries, ensuring effective governance and compliance[200]. - The internal control evaluation process included interviews, discussions, and sampling to identify and rectify deficiencies[200]. - Currency fluctuations, particularly in USD, can impact profits, and the company will continue to execute foreign exchange hedging strategies to mitigate this risk[165]. - The company has a comprehensive value management system and is focused on enhancing valuation through strategic initiatives[168]. - The company has disclosed its "Quality and Return Dual Improvement" action plan to enhance operational quality and shareholder returns[168].